Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Hepatitis C

  Free Subscription


Articles published in Clin Res Hepatol Gastroenterol

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    June 2019
  1. GOMEZ PA, Zucker KM, Chang J, Rowley MW, et al
    Severe pretreatment hepatic steatosis influences response to direct acting antiviral therapy for chronic hepatitis C in a real world setting.
    Clin Res Hepatol Gastroenterol. 2019 Jun 14. pii: S2210-7401(19)30101.
    PubMed     Text format    


    May 2019
  2. RAMEZANI A, Baesi K, Banifazl M, Mohraz M, et al
    Naturally occurring NS5A and NS5B resistant associated substitutions in HCV and HCV/HIV patients in iranian population.
    Clin Res Hepatol Gastroenterol. 2019 May 9. pii: S2210-7401(19)30043.
    PubMed     Text format     Abstract available


    April 2019
  3. SUN Q, Li J, Jin B, Wang T, et al
    Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage.
    Clin Res Hepatol Gastroenterol. 2019 Apr 30. pii: S2210-7401(19)30088.
    PubMed     Text format     Abstract available


    March 2019
  4. FABRIZIO F, Dixit V, Piergiorgio M
    Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2019 Mar 22. pii: S2210-7401(18)30225.
    PubMed     Text format     Abstract available


  5. COSTA VD, Delvaux N, Brandao-Mello CE, Nunes EP, et al
    Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1.
    Clin Res Hepatol Gastroenterol. 2019 Mar 14. pii: S2210-7401(19)30048.
    PubMed     Text format     Abstract available


    January 2019
  6. GHAZAL K, Morales O, Barjon C, Dahlqvist G, et al
    Early high levels of regulatory T cells and T helper 1 may predict the progression of recurrent hepatitis C after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2019 Jan 31. pii: S2210-7401(18)30221.
    PubMed     Text format     Abstract available


  7. PARLATI L, Pol S
    HCV-infected dialysis patients: History is changing.
    Clin Res Hepatol Gastroenterol. 2019 Jan 4. pii: S2210-7401(18)30279.
    PubMed     Text format    


    December 2018
  8. CUNHA LRD, Vieira DA, Giampietro YG, Gomes AD, et al
    Interleukin-10 promoter gene polymorphisms are associated with the first major depressive episode in chronic hepatitis C patients.
    Clin Res Hepatol Gastroenterol. 2018 Dec 24. pii: S2210-7401(18)30276.
    PubMed     Text format     Abstract available


    October 2018
  9. ALBERTI A, Angarano G, Colombo M, Craxi A, et al
    Optimizing patient referral and center capacity in the management of chronic hepatitis C: Lessons from the Italian experience.
    Clin Res Hepatol Gastroenterol. 2018 Oct 27. pii: S2210-7401(18)30189.
    PubMed     Text format     Abstract available


  10. PARLATI L, Sirmai L, Dupuy CA, Glotz D, et al
    Evidence of HCV recovery after therapy of hepatitis C virus infection by direct acting antivirals.
    Clin Res Hepatol Gastroenterol. 2018 Oct 4. pii: S2210-7401(18)30183.
    PubMed     Text format    


    August 2018
  11. MEKKY MA, Abdel-Malek MO, Osman HA, Abdel-Aziz EM, et al
    Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease.
    Clin Res Hepatol Gastroenterol. 2018 Aug 27. pii: S2210-7401(18)30147.
    PubMed     Text format     Abstract available


    May 2018
  12. PAVONE P, Alfieri G, Corano-Scheri G, Pinacchio C, et al
    Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs).
    Clin Res Hepatol Gastroenterol. 2018 May 4. pii: S2210-7401(18)30038.
    PubMed     Text format    


    December 2017
  13. NAJAFI FARD S, Schietroma I, Corano Scheri G, Giustini N, et al
    Direct-acting antiviral therapy enhances total CD4+ and CD8+ T-cells responses, but does not alter T-cells activation among HCV mono-infected, and HCV/HIV-1 co-infected patients.
    Clin Res Hepatol Gastroenterol. 2017 Dec 23. pii: S2210-7401(17)30262.
    PubMed     Text format     Abstract available


    August 2017
  14. MAROT A, Belaid A, Orlent H, Serste T, et al
    Characteristics of patients with hepatitis B virus and hepatitis C virus dual infection in a Western European country: Comparison with monoinfected patients.
    Clin Res Hepatol Gastroenterol. 2017 Aug 31. pii: S2210-7401(17)30134.
    PubMed     Text format     Abstract available


    July 2017
  15. ALI HEA, Abdel Hameed R, Effat H, Ahmed EK, et al
    Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2017 Jul 24. pii: S2210-7401(17)30148.
    PubMed     Text format     Abstract available


    May 2017
  16. MASCIA C, Lichtner M, Zuccala P, Vita S, et al
    Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-gamma)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection.
    Clin Res Hepatol Gastroenterol. 2017 May 31. pii: S2210-7401(17)30098.
    PubMed     Text format     Abstract available


  17. ALGOUD M, Tissot-Dupont H, Menard A, Botta-Fridlund D, et al
    Spontaneous clearance of chronic hepatitis C virus infection in HIV-positive patients, southeastern France.
    Clin Res Hepatol Gastroenterol. 2017 May 16. pii: S2210-7401(17)30096.
    PubMed     Text format    


    April 2017
  18. TARAMASSO L, Ricci E, Celesia BM, Bonfanti P, et al
    Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?
    Clin Res Hepatol Gastroenterol. 2017 Apr 21. pii: S2210-7401(17)30085.
    PubMed     Text format    


    January 2017
  19. LIAO H, Tan P, Zhu Z, Yan X, et al
    Sofosbuvir in combination with daclatasvir in liver transplant recipients with HCV infection: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2017 Jan 9. pii: S2210-7401(16)30207.
    PubMed     Text format     Abstract available


    November 2016
  20. BASSENDINE MF, Nielsen SU, Bridge SH, Felmlee DJ, et al
    Hepatitis C virus and atherosclerosis: A legacy after virologic cure?
    Clin Res Hepatol Gastroenterol. 2016 Nov 10. pii: S2210-7401(16)30138.
    PubMed     Text format     Abstract available


    April 2016
  21. QU Y, Li T, Wang L, Liu F, et al
    Efficacy and safety of simeprevir for chronic hepatitis virus C genotype 1 infection: A meta-analysis.
    Clin Res Hepatol Gastroenterol. 2016;40:203-12.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: